Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of Onsite, Rapid Antiretroviral Therapy (ART) Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program

NCT04650269 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT04650269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04650269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of Onsite, Rapid Antiretroviral Therapy (ART) Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program
Lead sponsor
University of Miami
Phase
Phase 4
Overall status
Completed
Start date
March 4, 2021
Completion date
December 31, 2023
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug use, harm reduction, hiv infections